Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has filed the notice for its 32nd AGM, to be held on Tuesday, September 30, 2025 at 1:00 PM via video conferencing. Ordinary business items include adoption of audited financial statements for FY ended March 31, 2025 and declaration of a final dividend of Re 0.01 per equity share (1% on face value of Rs 10). Other items include re-appointment of Mr. Dhruvin Shah (DIN: 08801616) as Executive Director, who retires by rotation, appointment of M/s Shah Sanghvi and Associates (FRN: 140107W) as new Statutory Auditors for a 5-year term until the 37th AGM in 2030, and appointment of Mrs. Rupal Patel as Secretarial Auditor for 5 consecutive years starting FY 2025-26. Record date for dividend entitlement is September 13, 2025; remote e-voting runs from September 27-29, 2025; book closure from September 24-30, 2025.
Routine annual governance exercise. The declared dividend is very small (Re 0.01 per share), so no meaningful income for shareholders. The change of statutory auditors and re-appointment of the MD's son (Mr. Dhruvin Shah) are notable governance items but unlikely to move the stock on their own.